Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
QuidelOrtho Corporation (QDEL)  
$42.22 2.54 (6.4%) as of 4:30 Thu 5/2


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 66,921,000
Market Cap: 2.83(B)
Last Volume: 1,212,774 Avg Vol: 1,001,263
52 Week Range: $38.26 - $89.25
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue™, Lyra®, FreshCells™, D3®, FastPoint®, ReadyCells®, Super E-Mix™, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 799
  Page 7 of 32  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bryant Douglas C President & CEO   •       •      –    2021-02-15 4 D $227.97 $2,288,819 D/D (10,040) 468,047     -
   Bryant Douglas C President & CEO   •       •      –    2021-02-15 4 A $0.00 $0 D/D 20,250 478,087     -
   Bujarski Robert Joseph Chief Operating Officer   •       –      –    2021-02-15 4 D $227.97 $810,661 D/D (3,556) 18,545     -
   Bujarski Robert Joseph Chief Operating Officer   •       –      –    2021-02-15 4 A $0.00 $0 D/D 7,172 22,101     -
   Gibson Karen SVP, Digital Health   •       –      –    2021-02-15 4 D $227.97 $429,268 D/D (1,883) 6,105     -
   Gibson Karen SVP, Digital Health   •       –      –    2021-02-15 4 A $0.00 $0 D/D 3,797 7,988     -
   Kroll Werner SVP, R&D   •       –      –    2021-02-04 4 D $228.68 $501,267 D/D (2,192) 8,225     -
   Kroll Werner SVP, R&D   •       –      –    2021-02-04 4 A $0.00 $0 D/D 4,268 10,417     -
   Bryant Douglas C President & CEO   •       •      –    2021-02-03 4 D $236.85 $445,752 D/D (1,882) 457,736     -
   Bryant Douglas C President & CEO   •       •      –    2021-02-03 4 A $0.00 $0 D/D 3,795 459,618     -
   Ferenczy William J. SVP, Cardio/Metabolic Unit   •       –      –    2021-02-03 4 D $236.85 $53,528 D/D (226) 4,888     -
   Ferenczy William J. SVP, Cardio/Metabolic Unit   •       –      –    2021-02-03 4 A $0.00 $0 D/D 653 5,114     -
   Steward Randall J Chief Financial Officer   •       –      –    2021-02-03 4 D $236.85 $591,651 D/D (2,498) 6,487     -
   Steward Randall J Chief Financial Officer   •       –      –    2021-02-03 4 A $0.00 $0 D/D 5,616 8,985     -
   Ranalli Tamara A. SVP, Molecular Bus. Unit   •       –      –    2021-02-03 4 D $236.85 $34,343 D/D (145) 9,302     -
   Ranalli Tamara A. SVP, Molecular Bus. Unit   •       –      –    2021-02-03 4 A $0.00 $0 D/D 593 9,447     -
   Russell Edward Keith SVP, Business Development   •       –      –    2021-02-03 4 D $236.85 $136,189 D/D (575) 18,276     -
   Russell Edward Keith SVP, Business Development   •       –      –    2021-02-03 4 A $0.00 $0 D/D 1,661 18,851     -
   Bujarski Robert Joseph Chief Operating Officer   •       –      –    2021-02-03 4 D $236.85 $187,348 D/D (791) 14,929     -
   Bujarski Robert Joseph Chief Operating Officer   •       –      –    2021-02-03 4 A $0.00 $0 D/D 1,661 15,720     -
   Gibson Karen SVP, Digital Health   •       –      –    2021-02-03 4 D $236.85 $195,164 D/D (824) 4,151     -
   Gibson Karen SVP, Digital Health   •       –      –    2021-02-03 4 A $0.00 $0 D/D 1,661 4,975     -
   Kroll Werner SVP, R&D   •       –      –    2021-01-29 4 D $250.97 $382,980 D/D (1,526) 6,149     -
   Kroll Werner SVP, R&D   •       –      –    2021-01-29 4 A $0.00 $0 D/D 2,970 7,675     -
   Gibson Karen SVP, Digital Health   •       –      –    2021-01-29 4 D $250.97 $282,592 D/D (1,126) 3,314     -
  799 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 32
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us